News about Global Pharma

Bayer Acquires Zydus Pharma with Full Ownership

Bayer Pharmaceuticals Private Ltd. and Zydus Lifesciences Ltd. have announced the successful conclusion of their joint venture (JV) - Bayer Zydus Pharma Private Ltd. (BZPPL).

Global Pharma | 03/05/2024 | By Aishwarya |  1216

Myonex Acquires Creapharm to Expand Global Services

Myonex has completed the acquisition of CREAPHARM’s pharmaceutical services business.

Global Pharma | 03/05/2024 | By Aishwarya |  550

BrioHealth Solutions Receives FDA Approval to Begin Trial for Advanced Heart Failure Solution

The BrioVAD Left Ventricular Assist System offers both temporary and long-term support solutions for patients suffering from advanced heart failure.

Global Pharma | 03/05/2024 | By Abha |  695

MCRA Facilitates FDA Approval for Darmiyan's De Novo request for BrainSee

Darmiyan retained MCRA in 2021 for its broad and deep experience in Neurology, Digital Health, and Artificial Intelligence (AI).

Global Pharma | 03/05/2024 | By Abha |  879

Maiva Pharma Raises INR 1,000 Crore from Fundraising

Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).

Global Pharma | 03/05/2024 | By Aishwarya |  1042

Bound Tree Medical to Acquire QuadMed

Bound Tree Medical announced that the company has signed a definitive agreement to acquire QuadMed, Inc. Following a thoughtful integration period of 60-90 days, Bound Tree will seamlessly assume full operation of QuadMed's business, serving customers serving customers under the Bound Tree brand name.

Global Pharma | 02/05/2024 | By Manvi |  503

PainTEQ Gets Two New Patents for the LinQ Procedure, Advancing Treatments for SI Joint Dysfunction

These patents mark a notable step forward in medical device innovation, offering new hope to thousands suffering from debilitating lower back pain.

Global Pharma | 02/05/2024 | By Manvi |  839

Granules India Limited Gets ANDA Approval for Colchicine Capsules

Granules India Ltd. has declared that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, for Colchicine Capsules, 0.6 mg.

Global Pharma | 02/05/2024 | By Aishwarya |  790

United Imaging Receives FDA Clearance for uMR Jupiter 5T MRI System

The uMR Jupiter is hailed as the first ultra-high field system cleared for whole-body applications, setting a new standard in the field.

Global Pharma | 02/05/2024 | By Aishwarya |  1278

Medison Pharma and Alnylam Pharmaceuticals Expand Partnership to Reach More Patients Globally

Medison has developed a unique commercialization platform focused on delivering cutting-edge treatments for rare and severe diseases.

Global Pharma | 02/05/2024 | By Abha |  1392